bovnews26m
What’s Behind the -12.03% Drop in FiscalNote Holdings Inc (NOTE) Stock? Find Out Now!
FiscalNote Holdings Inc (NOTE) stock saw a decline, ending the day at $1.17 which represents a decrease of $-0.16 or -12.03% from the prior close of $1.33. The stock opened at $1.28 and touched a low ...
Hosted on MSN2d
BTIG Initiates Coverage of Hims & Hers Health (HIMS) with Buy Recommendation
Fintel reports that on January 7, 2025, BTIG initiated coverage of Hims & Hers Health (NYSE:HIMS) with a Buy recommendation.
BTIG Sticks to Their Buy Rating for Stryker (SYK)
BTIG analyst Ryan Zimmerman maintained a Buy rating on Stryker (SYK – Research Report) yesterday and set a price target of $394.00. The ...
24/7 Wall St. on MSN3d
Large-Cap Value Stocks Could Rule in 2025: 4 High-Yield Dividend Winners
Here are four large-cap value stocks that growth and income investors may want to consider now. History suggests they will ...
Traders Magazine9y
BTIG Expands Transition Management, Hires Howell to Boost Business
BTIG is growing its transition management business and hired a senior executive to help boost business. The firm has hired Daniel Howell as a director who will be based in New York. His job is ...
Nasdaq6d
BTIG sees Uber Q4 bookings more in middle than high-end of outlook
BTIG analyst Jake Fuller says that while Uber‘s (UBER) commentary on its U.S. rideshare business “felt constructive” at intra-quarter appearances, the firm’s receipt data was “more ...
Stock rally faces resistance: BTIG's Krinsky
The S&P 500's rally of 1.8% over just the last two sessions is nice, "but not a game changer yet," according to BTIG's technical guru, Jonathan Krinsky. The chart he provides, below, shows the stock ...
Glaukos price target raised to $157 from $149 at BTIG
BTIG raised the firm’s price target on Glaukos (GKOS) to $157 from $149 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models on Medical Technology names ...
Here are some of BTIG's top picks for the first half of 2025
BTIG's Krinsky noted that while equity markets in the first half of 2024 were fueled mostly by the surge in mega-cap names ...
GeneDx management to meet with BTIG
BTIG Life Sciences and Diagnostic Tools Analyst Massaro holds group dinner meeting with CEO Stueland and CFO Feeley on January 13 at 10:30 am.